BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lawal B, Kuo YC, Sumitra MR, Wu ATH, Huang HS. In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. J Inflamm Res 2021;14:4901-13. [PMID: 34588796 DOI: 10.2147/JIR.S329401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Shen W, Anuraga G, Khoa Ta HD, Xuan DTM, Chen S, Shen C, Jiang J, Sun Z, Wang C, Wang W. Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer. JPM 2022;12:1947. [DOI: 10.3390/jpm12121947] [Reference Citation Analysis]
2 Shih M, Lee J, Cheng S, Lawal B, Ho C, Wu C, Tzeng DT, Chen J, Wu AT. Transcriptomic discovery of a theranostic signature (SERPINE1/MMP3/COL1A1/SPP1) for head and neck squamous cell carcinomas and identification of antrocinol as a candidate drug. Computers in Biology and Medicine 2022;150:106185. [DOI: 10.1016/j.compbiomed.2022.106185] [Reference Citation Analysis]
3 Ku S, Liu H, Su C, Yeh I, Yen M, Anuraga G, Ta HDK, Chiao C, Xuan DTM, Prayugo FB, Wang W, Wang C. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer. Aging 2022. [DOI: 10.18632/aging.204357] [Reference Citation Analysis]
4 Alozieuwa UB, Lawal B, Sani S, Onikanni AS, Osuji O, Ibrahim YO, Babalola SB, Mostafa-hedeab G, Alsayegh AA, Albogami S, Batiha GE, Wu ATH, Huang H, Conte-junior CA, Gonçalves-de-albuquerque CF. Luteolin-Rich Extract of Thespesia garckeana F. Hoffm. (Snot Apple) Contains Potential Drug-Like Candidates and Modulates Glycemic and Oxidoinflammatory Aberrations in Experimental Animals. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/1215097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lawal B, Kuo YC, Rachmawati Sumitra M, Wu ATH, Huang HS. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone. Comput Biol Med 2022;148:105814. [PMID: 35841781 DOI: 10.1016/j.compbiomed.2022.105814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lawal B, Wu ATH, Huang HS. Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule. Front Immunol 2022;13:872470. [PMID: 35655775 DOI: 10.3389/fimmu.2022.872470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Onikanni AS, Lawal B, Oyinloye BE, Mostafa-hedeab G, Alorabi M, Cavalu S, Olusola AO, Wang C, Batiha GE. Therapeutic efficacy of Clompanus pubescens leaves fractions via downregulation of neuronal cholinesterases/Na+-K+ATPase/IL-1 β, and improving the neurocognitive and antioxidants status of streptozotocin-induced diabetic rats. Biomedicine & Pharmacotherapy 2022;148:112730. [DOI: 10.1016/j.biopha.2022.112730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
8 Cheng S, Wu ATH, Batiha GE, Ho C, Lee J, Lukman HY, Alorabi M, Alrasheedi AN, Chen J. Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin. Biology 2022;11:324. [DOI: 10.3390/biology11020324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Onikanni AS, Lawal B, Olusola AO, Olugbodi JO, Sani S, Ajiboye BO, Ilesanmi OB, Alqarni M, Mostafa-Hedeab G, Obaidullah AJ, Batiha GE, Wu ATH. Sterculia tragacantha Lindl Leaf Extract Ameliorates STZ-Induced Diabetes, Oxidative Stress, Inflammation and Neuronal Impairment. J Inflamm Res 2021;14:6749-64. [PMID: 34916823 DOI: 10.2147/JIR.S319673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
10 Chiao CC, Liu YH, Phan NN, An Ton NT, Ta HDK, Anuraga G, Minh Xuan DT, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wu YF, Lee KH, Chuang JY, Wang CY, Kao TJ. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer. Diagnostics (Basel) 2021;11:2220. [PMID: 34943457 DOI: 10.3390/diagnostics11122220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yeh YC, Lawal B, Hsiao M, Huang TH, Huang CF. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines 2021;9:1582. [PMID: 34829812 DOI: 10.3390/biomedicines9111582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Wu ATH, Lawal B, Wei L, Wen YT, Tzeng DTW, Lo WC. Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate. Pharmaceutics 2021;13:1555. [PMID: 34683848 DOI: 10.3390/pharmaceutics13101555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]